Strs Ohio acquired a new stake in shares of Maximus, Inc. (NYSE:MMS - Free Report) in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm acquired 3,700 shares of the health services provider's stock, valued at approximately $252,000.
A number of other hedge funds have also recently bought and sold shares of MMS. Caitong International Asset Management Co. Ltd grew its position in shares of Maximus by 17,533.3% in the 1st quarter. Caitong International Asset Management Co. Ltd now owns 529 shares of the health services provider's stock worth $36,000 after acquiring an additional 526 shares in the last quarter. UMB Bank n.a. lifted its holdings in shares of Maximus by 70.2% in the 1st quarter. UMB Bank n.a. now owns 606 shares of the health services provider's stock worth $41,000 after purchasing an additional 250 shares during the last quarter. GAMMA Investing LLC lifted its holdings in shares of Maximus by 67.1% in the 1st quarter. GAMMA Investing LLC now owns 732 shares of the health services provider's stock worth $50,000 after purchasing an additional 294 shares during the last quarter. NBC Securities Inc. lifted its holdings in shares of Maximus by 114,900.0% in the 1st quarter. NBC Securities Inc. now owns 1,150 shares of the health services provider's stock worth $78,000 after purchasing an additional 1,149 shares during the last quarter. Finally, Blue Trust Inc. lifted its holdings in shares of Maximus by 32.8% in the 1st quarter. Blue Trust Inc. now owns 1,228 shares of the health services provider's stock worth $84,000 after purchasing an additional 303 shares during the last quarter. Institutional investors and hedge funds own 97.21% of the company's stock.
Maximus Stock Up 0.3%
MMS opened at $87.77 on Thursday. Maximus, Inc. has a one year low of $63.77 and a one year high of $93.94. The company has a debt-to-equity ratio of 0.91, a quick ratio of 2.27 and a current ratio of 2.27. The stock's fifty day moving average is $82.57 and its 200-day moving average is $74.28. The company has a market capitalization of $4.95 billion, a PE ratio of 16.16 and a beta of 0.61.
Maximus (NYSE:MMS - Get Free Report) last posted its quarterly earnings data on Thursday, August 7th. The health services provider reported $2.16 EPS for the quarter, topping analysts' consensus estimates of $1.39 by $0.77. The company had revenue of $1.35 billion for the quarter, compared to the consensus estimate of $1.29 billion. Maximus had a return on equity of 24.44% and a net margin of 5.83%.The company's quarterly revenue was up 2.5% compared to the same quarter last year. During the same quarter in the previous year, the business earned $1.74 EPS. Maximus has set its FY 2025 guidance at 7.350-7.550 EPS. On average, equities analysts predict that Maximus, Inc. will post 6.15 EPS for the current fiscal year.
Maximus Dividend Announcement
The business also recently announced a quarterly dividend, which was paid on Sunday, August 31st. Investors of record on Friday, August 15th were issued a $0.30 dividend. This represents a $1.20 dividend on an annualized basis and a dividend yield of 1.4%. The ex-dividend date was Friday, August 15th. Maximus's payout ratio is presently 22.10%.
Analyst Ratings Changes
Separately, Zacks Research raised Maximus from a "hold" rating to a "strong-buy" rating in a research note on Tuesday, August 26th. One analyst has rated the stock with a Strong Buy rating and one has given a Buy rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of "Strong Buy" and an average price target of $90.00.
Read Our Latest Research Report on MMS
Maximus Profile
(
Free Report)
Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.
Recommended Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Maximus, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Maximus wasn't on the list.
While Maximus currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for October 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.